Cannabis Panaxia and Neuraxpharm to distribute medical pot in Czech Republic and Switzerland Panaxia will manage manufacturing with Neuraxpharm responsible for marketing and distribution Rowan DunneOctober 7, 2022
Cannabis Khiron reaches new medical revenue records in Q1 Company growth within Colombia and Europe responsible for financial success this quarter Rowan DunneJune 1, 2022
Business Tilray chosen as supplier of medical pot in Luxembourg CEO Irwin Simon says EU markets represent a $1-billion opportunity to his firm Nick LabaOctober 26, 2021
International How to build Europe’s largest medical cannabis company: Kanabo CEO Q&A Avihu Tamir explains why his company is set to lead the pack in one of the world's fastest-expanding pot economies Nick LabaAugust 5, 2021
News Tilray 1.0 quietly discloses first-quarter US$341M loss In the final quarter before merging with Aphria, Tilray shows fiscal weakness Jared GnamMay 11, 2021
News Curaleaf plans to stay on top of US pot boom After posting an industry-leading US$260M in Q1, the American weed giant eyes domination in NY, NJ and internationally Jared GnamMay 11, 2021
Analysis Writedowns and growing pains ahead for Tilray 2.0, analyst says But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market Jared GnamMay 3, 2021
Industry update Switzerland to launch Europe’s first adult-use cannabis market this year The Swiss government has released draft rules to introduce an experimental recreational market as early as May 15 Jared GnamApril 5, 2021
Industry update Curaleaf expands cannabis empire into Europe, posts record Q4 sales America's biggest pot operator says it expects to report at least US$1.2B in revenue for fiscal 2021 Jared GnamMarch 10, 2021
Analysis Is Hexo blowing smoke on Euro entry via Zenabis deal? While Hexo says a recent acquisition deal gives it 'immediate access' to Europe, records show Zenabis has yet to sell a gram in the... Jared GnamFebruary 24, 2021